The effects of opioid receptor blockade on experimental panic provocation with CO2

Journal of Psychopharmacology

Volumn 23, Issue 8, 2009, Pages 975-978

  Esquivel, G ^a   Fernandez Torre, O ^b   Schruers, K R J ^a   Wijnhoven, L L W ^a   Griez, E J L ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

35 CO2 inhalation; Anxiety; Naltrexone; Opioids; Panic

Indexed keywords

CARBON DIOXIDE; NALTREXONE; OPIATE; OPIATE RECEPTOR; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXPERIMENT; FEMALE; HUMAN; MALE; MEASUREMENT; MENTAL CONCENTRATION; PANIC; PRIORITY JOURNAL; PROVOCATION TEST; RECEPTOR BLOCKING; SIDE EFFECT; SOMNOLENCE; SYMPTOM; VOLUNTEER;

ADULT; CARBON DIOXIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NALTREXONE; PANIC DISORDER; RECEPTORS, OPIOID;

EID: 70449353777     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108093844     Document Type: Article

References (15)

1. Akiyama, Y., Nishimura, M., Kobayashi, S., Yoshioka, A., Yamamoto, M., Miyamoto, K., et al. (1993) Effects of naloxone on the sensation of dyspnea during acute respiratory stress in normal adults. J Appl Physiol 74: 590-595.
2. Battaglia, M., Perna, G. (1995) The 35% CO2 challenge in panic disorder: optimization by receiver operating characteristic (ROC) analysis. J Psychiatr Res 29: 111-119.
3. Cohen, MR, Cohen, RM, Pickar, D., Weingartner, H., Murphy, DL (1983) High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses. Arch Gen Psychiatry 40: 613-619.
4. Gonzalez, JP, Brogden, RN (1988) Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 35: 192-213.
5. Griez, EJ, Colasanti, A., van Diest, R., Salamon, E., Schruers, K. (2007) Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity. PLoS ONE 2: e987.
6. Jennings, AL, Davies, AN, Higgins, JP, Gibbs, JS, Broadley, KE (2002) A systematic review of the use of opioids in the management of dyspnoea. Thorax 57: 939-944.
7. Liebowitz, MR, Fyer, AJ, Gorman, JM, Dillon, D., Appleby, IL, Levy, G., et al. (1984 a) Lactate provocation of panic attacks. I. Clinical and behavioral findings. Arch Gen Psychiatry 41: 764-770.
8. Liebowitz, MR, Gorman, JM, Fyer, AJ, Dillon, DJ, Klein, DF (1984 b) Effects of naloxone on patients with panic attacks. Am J Psychiatry 141: 995-997.
9. Luby, ED, Marrazzi, MA (1987) A panic attack precipitated by opiate blockade-a case study. J Clin Psychopharmacol 7: 361-362.
10. Maremmani, I., Marini, G., Fornai, F. (1998) Naltrexone-induced panic attacks. Am J Psychiatry 155: 447.
11. Poma, SZ, Milleri, S., Squassante, L., Nucci, G., Bani, M., Perini, GI, et al. (2005) Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects. J Psychopharmacol 19: 494-503.
12. Preter, M., Klein, DF (2008) Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsychopharmacol Biol Psychiatry 32: 603-612.
13. Sheehan, DV, Lecrubier, Y., Sheehan, KH, Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl. 20). 22-33 ; quiz 34-57.
14. Sinha, SS, Goetz, RR, Klein, DF (2007) Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder. Psychiatry Res 149: 309-314.
15. Yassen, A., Olofsen, E., van Dorp, E., Sarton, E., Teppema, L., Danhof, M., et al. (2007) Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone: a study in healthy volunteers. Clin Pharmacokinet 46: 965-980.